HC Wainwright reaffirmed their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a report issued on Tuesday morning, Benzinga reports. HC Wainwright currently has a $7.00 target price on the stock. Enlivex Therapeutics Stock Down 3.3 % Enlivex Therapeutics stock opened at $1.45 on Tuesday. Enlivex Therapeutics has a one year […]